CytomX Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswireJan 8 08:00 ET

Piper Sandler Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $3.25

Moomoo NewsJan 8 05:36 ET · Ratings

Wedbush Maintains CytomX(CTMX.US) With Buy Rating, Cuts Target Price to $5

Moomoo NewsJan 7 09:31 ET · Ratings

CytomX Therapeutics (CTMX) Receives a Buy From Wedbush

TipRanksJan 7 09:06 ET · Ratings

Express News | CytomX Therapeutics Inc : Wedbush Cuts Target Price to $5 From $8

ReutersJan 7 06:57 ET

HC Wainwright & Co. Reiterates Neutral on CytomX Therapeuticsto Neutral

BenzingaJan 7 06:32 ET